MMI188A Final Exam

0.0(0)
Studied by 0 people
call kaiCall Kai
learnLearn
examPractice Test
spaced repetitionSpaced Repetition
heart puzzleMatch
flashcardsFlashcards
GameKnowt Play
Card Sorting

1/260

flashcard set

Earn XP

261 Terms

1
New cards

Vaccination

  • can generate lifelong immunological memory

  • specific antibodies continue to be made for as long as 75 years after the last exposure to the vaccinia virus

  • many vaccinated individuals also retain populations of vaccinia-specific CD4 T cells and CD8 T cells

  • is a process of introducing a harmless form or component of a pathogen to stimulate the body's immune response. This leads to the production of antibodies and memory cells, enabling long-term protection against future infections


2
New cards

secondary immune response

  • The ability of the immune system to remember and respond more effectively to pathogens it has previously encountered, providing long-lasting protection.

  • memory responses are generally

    • faster, stronger and longer responses

    • eliminates pathogens before it can cause disease

    • circulating antibody, with long-lived specific B and T cells

    • antibodies can last several months

  • close cooperation b/w innate and adaptive immunity from start of infection

  • specific antibodies are already present

  • effector T cells are present and activated in the infected tissue


3
New cards

Immunological memory

low steady state level of antibodies that allow immune response to happen faster


  • this second immune response to the pathogen was mediated by high-affinity pathogen-specific IgG, memory T cells and memory B cells


4
New cards

Memory Cells compared to Naive Lymphocytes are

  • more sensitive to detection of infection

  • easier to activate because they require no signals

  • more abundant for their specific pathogens


5
New cards

What does the primary immune response produce?

  • Effector B cells

  • effector T cells

  • memory B cells

  • memory T cells

  • More effector than memory cells are produced, only a small amount of them actually become memory cells


6
New cards

Pathogen-specific memory B cells

  • more abundant and make better antibodies than naive B cells

  • more sensitive to specific antigen and therefore can response more quickly

  • make higher affinity antibody and higher affinity of antigen receptor (B cell receptor)

  • higher levels of MHC Class II and co-stimulatory molecules

  • get antibodies faster, in 4 days instead of 8 days


7
New cards

Cells of Immunological Memory

  • long-lived plasma cells that can individually live years to decades

    • they are unique because they are fully differentiated and do not need a clone to replicate

  • Memory T cells can live for decades. All T cells are clones that replace themselves by proliferation

  • Memory B cells can live for decades


8
New cards

How do B cells participate in the secondary immune response. What kinds of B cells participate?

  • only memory B cells participate in the secondary immune response

  • IgG suppresses activation of naive B cells by crosslinkgin the B cell receptor and the inhibitory Fc receptor

  • In early stage of primary immune response, pathogen binding to antigen receptor of naive B cell signals it to activate to become a plasma cell.

  • during later stages, the B cell receptor and inhibitory Fc receptor FcγRIIB1 on a naive B cell can be cross-linked by a pathogen coated with IgG. This delivers a signal that prevents the naive B cells from being activated.

  • Since memory B cells activated in a secondary response do not express FcγRIIB1, they are able to produce antibodies.


TLDR: If a pathogen in your system is already coated with IgG, that means antibodies are already being secreted to target this pathogen. Therefore, when the pathogen comes into the vicinity, it is already being coated with IgG. When a naive B cell tries to bind to it and activate, the Fc receptor of the IgG will bind to FcγRIIB1, inactivating the naive B cell. Naive B cell will not be able to activate. The memory B Cell does not have the FcγRIIB1 receptor, so it will bind the pathogen and secrete more high-affinity IgG.


9
New cards

How can vaccination induce a primary immune response?

  • the first encounter of a pathogen can be done through vaccinations

    • this means that when you actually encounter the pathogen, your immune response will have already been introduced to this pathogen because you got vaccinated


10
New cards

RhD+/- antigens,

  • up to 16% of individuals lack the erythrocyte antigen Rhesus D (RhD)

  • in the US, 85% of people are RhD positive, 15% are RhD negative

  • RhD is a surface protein antigen, and RBCs in your body are either RhD+ or - in each person

  • when an RhD- mother marries an RhD+ father, the mother carries an RhD+ fetus in her first pregnancy, this induces a primary immune response because the RhD- mother has never seen the RhD+ antigens

    • there are minor destruction of fetal erythrocytes by anti-RhD IgG. This is only minor because it’s a primary immune response

  • however, if the mother has subsequent pregnancies, a secondary immune response will be activated, which will lead to mass destruction of fetal erythrocytes triggered by anti-RhD IgGs

    • complement-mediated hemolysis of fetal erythrocytes results in a lack of sufficient cells for proper oxygenation of the fetus


11
New cards

Passive immunization with anti-RhD antigen IgG

  • to ensure newborn babies aren’t born anemic with Hemolytic Disease of the Newborn (HDN), mothers can be passively infuse with purified human anti-RhD antibodies during their first and subsequent pregnancies

  • anti-RhD antibodies coat the fetal erythrocytes with IgG to prevent the mother from making a primary B-cell response against the RhD antigen

    • this is similar to how new naive B cells are not activated in a secondary immune response because an abundant amount of antibodies already exist for that specific antigen

  • drug used is called WinRho SDF, also known as the Winnipeg-born Rh-factor antibody treatment


12
New cards

Transition of short-lived plasma cells to long-lived plasma cells

  • responding to infection, a large wave of short-lived plasma cells is

    followed by a smaller, selected group of long-lived plasma cells

  • short-lived plasma cells last for weeks, long-lived plasma cells last for decades that persist in specialized niches


13
New cards

Escaping Immunological Memory

  • an example is Influenza

    • highly mutable virus that has multiple epitopes

    • influenza mutates rapidly, which is why a new vaccine is needed every year

    • in the first year, influenza could cause a primary antibody response to the epitopes A, B, C, and D. but as time passes, this strain could get mutated to A, B, C, and E. this makes the antibodies specified for ABCD weaker, until the strain gets fully mutated into a new strand such as EGFH. This EGFH strain would then require a whole new primary response


14
New cards

Antigenic Drift

Antigenic variation in Influenza due to accumulation of point mutations

15
New cards

Antigen activation of Naive CD8 T cells and generation of Memory T cells

On activation, naive CD8 T cells:

  • Becomes metabolically reprogrammed

  • Can undergo asymmetric division to give one daughter cell that is an Effector T cell (TE) and one that is a Memory T cell (TM)


Process: Naive CD8 T cell is activated by specific antigen, is then reprogrammed and enters mitosis. However undergoing mitosis, it also undergoes asymmetric division. This leads to one effector T cell and one memory T cell


16
New cards

Different Isoforms of CD45

  • make memory T cells easier to activate than naive T cells

  • Naive T cells make CD45RA

  • memory T cells make CD45RO

  • CD45RA is bigger than CD45RO and less able to interact with the T-cell receptor complex and activate T cells

    • therefore memory T cells express an isoform that associates better with the T cell receptor complex


17
New cards

CD45

transmembrane tyrosine phosphatase involved in T cell activation

  • through differential mRNA splicing, CD45 can be made into two isoforms, CD45RA and CD45RO


18
New cards

Cell-Surface Phenotypes

CD44: for cell adhesion, present in naive, effector and memory T cells, but more commonly effector and memory

CD45RO: tyrosine phosphatase present in all 3 but more commonly effector and memory

CD45RA: tyrosine phosphatase present in all 3 but more commonly naive

IFN-gamma: cytokine present in effector and memory T Cells

CD25: IL-2 receptor present in effector T cells

CD127: IL-7 receptor present in naive and memory T cells

19
New cards

Memory T cells and their patterns of Migration

  • central memory T cells circulate between blood, lymph and secondary lymphoid tissues

  • effector memory T cells circulate from blood to non-lymphoid tissues and then return in the lymph to the blood

  • resident memory T cells are based in non-lymphoid tissues where they can rapidly respond to local infections


20
New cards

Memory B cells

  • do not require co-stimulation through CD28

  • undergo further

    • somatic hypermutation

    • affinity maturation

    • isotype switching

  • more immunization = increase in amount and affinity of antibodies


21
New cards

Modern Vaccinology

  • Edward Jenner used vaccination with cowpox to protect people against smallpox

  • Cowpox also elicits T-cell immunity that cross-reacts with smallpox



22
New cards

Vaccine

  • preparation of the causative agent in a form that is capable of inducing immunity but unable to cause disease

  • stimulation adaptive immune response that will protect against future infection


23
New cards

Two Key elements of Adaptive Immunity

Specificity and Memory

24
New cards

Seroprotective threshold

  • immune response level necessary for protection


25
New cards

Factors that influence the immune response to vaccination

  • age (babies only have maternal antibodies, elderly have weakened immune system)

  • immunodeficiency

  • genetic factors (MHC)

  • nutritional state

  • storage conditions of vaccines

  • dose and administration route

  • any underlying illnesses

  • vaccine expiration


26
New cards

Herd Immunity

  • proportion of people immune to an infection is sufficiently high that transmission of the infection to susceptible individuals is greatly reduced

  • helps to protect those who are susceptible and cannot be immunized

    • i.e. Live vaccines for pregnant women and immunocompromised patients


27
New cards

Impact of Misinformation on vaccines

  • link between the MMR vaccine and autism was falsely alleged

    • number of children vaccinated decreased

  • outbreaks of measles increased in both frequency and size


28
New cards

Measles Complications - Subacute Sclerosing Panencephalitis (SSPE)

  • brain disease that is a late consequence of measles infection in some individuals

  • progressive neurological disorder characterized by inflammation of the brain

  • may develop due to reactivation of the measles virus or an inappropriate immune response to the measles virus

  • develops 2 to 10 years after the original viral attack

  • initial symptoms may include memory loss, irritability, seizures, involuntary muscle movements, and behavioral changes, leading to neurological deterioration


29
New cards

Success in Vaccination

  • Dramatic reduction in death and suffering from vaccine-preventable diseases

  • Dramatic decline in the incidence of diseases in countries with high vaccination coverage

  • The eradication of smallpox

  • Reduction in healthcare costs due to disease prevention

  • Reduction in cost to society (workdays lost)


30
New cards

Live Attenuated Viral Vaccines

  • Attenuated

    • virus that cannot cause the disease, but still possesses antigenic properties and can induce a protective immune response

    • prepared by repeated subculture or serial passage in various animal hosts

  • Mimics natural infection

  • multiplies in the individual

    • stimulation of both humoral and cellular immune responses

    • risk of reversion to virulence


31
New cards

How are attenuated viruses selected for?

  • growing human viruses in non-human cells

    • virus is first grown in quantity in human tissue culture cell. it is then isolated and grown in a non-human species (i.e. monkey) until it adapts fully to the non-human cell

      • a consequence of this is growing poorly in the human cell, therefore, this attenuated virus is present in amounts that can stimulate an immune response, but is usually not enough to cause a disease

  • examples of live attenuated viruses are MMR, chickenpox and rotavirus


32
New cards

Smallpox Eradication

smallpox was able to be eradicated because

  • no animal reservoir known

  • lifelong immunity upon vaccination/infection

  • subclinical cases were very rare

  • infectivity low before symptoms appear

  • only one single serotype


33
New cards

Concerns about Live Viral Vaccines

  • reversion to virulence since it is composed of live attenuated viral mutants

  • excretion of the live vaccine by the immunized person to infect others

  • contamination of the vaccine with a second virus during attenuated virus production


34
New cards

SV40 Simian Virus 40

  • Some polio vaccines used in the late 1950s and early 1960s were contaminated with called simian virus 40

    • present in monkey kidney cells used to grow the vaccine

  • SV40 was present in cancers of people who either had or had not received the polio vaccines that were contaminated with SV40


35
New cards

Killed Viral Vaccines

  • Contain purified killed virions in sufficiently high concentrations to induce immunity

  • Advantages:

    • cannot revert to virulence

    • more heat stable

    • can be safely given to immunodeficient patients and pregnant women

  • Disadvantages

    • needs several doses for full immunity

    • shorter duration of protection and is less protective in general

    • induces a weaker mucosal sIgA antibody response

Examples: Hepatitis A, Influenza, Rabies, Polio

36
New cards

Subunit Viral Vaccines

  • Contains the immunity-inducing component of the virion

    • Proteins purified from virus particles

    • Recombinant proteins

  • No reversion possible

  • Less immunogenic by itself

Example: Hepatitis B, Shingles Vaccine, HPV vaccine, recombinant influenza vaccine

37
New cards

Recombinant Vaccines

  • Produced by viral or bacterial strains that have been genetically engineered to express the genes of pathogens

  • advantages

    • purified combinant protein does not contain viral nucleic acid, cannot revert to virulence

    • no contaminating viruses

    • easily produced in large amounts and inexpensive


38
New cards

Hepatitis B Virus Vaccine

  • Consist of Hepatitis B surface Antigen (HBsAg)

  • First vaccine preparations were made from the blood of infected people

  • Now - recombinant HBsAg (Engerix-B)

    • gives 85% immunity

    • non-responders are usually people whose HLA Class II allotypes fail to present the HbsAg derived peptides


39
New cards

Polio Vaccines

Sabin attenuated vaccine

  • Attenuated by passage in foreign host (kidney cells from African green monkeys)

  • Selection to grow in new host made virus less suited to original  host

  • Grows in epithelial cells (small intestine)

  • Does not grow in nerve ganglia

  • No paralysis

  • Local mucosal immunity (sIgA)


Salk killed polio vaccine

  • Weaker immunogen that does not induce mucosal immunity but protects against paralysis.

  • safer than sabin attenuated


Now, people take the inactivated vaccine over the oral vaccine because polio is less common

40
New cards

Properties of Viral Vaccines

Live-Attenuated

  • longer duration of immunity

  • greater effectiveness of protection

  • sIgA and IgG produced

  • possible reversion to virulence

  • low room temperature stability

  • possible virus excretion and transmission to non-immune contacts


Killed

  • shorter duration of immunity

  • less protective

  • iGG produced

  • no reversion to virulence

  • high room temperature stability

  • no virus excretion and transmission to non-immune contacts


41
New cards

Bacterial Vaccine Immunogens

Polysaccharide Capsule

  • Antibodies binding to the bacterial capsule neutralize the antiphagocytic effect of the capsule

Adherence pili

  • Antibodies to pili block adherence of bacteria to cells


Examples of Bacterial Vaccines: DTaP

42
New cards

Toxoids

  • Non-toxic, immunogenic preparations of toxins

  • Heat or chemically treated

  • Immunization with toxoid is efficacious for 1 year

  • Booster immunizations may be needed

  • Addition of adjuvants enhances immunogenicity

    • Adjuvants are molecules that are added to vaccines to enhance their immunogenicity.


43
New cards

DTaP

Combination Vaccine against Diphtheria, Tetanus, and Pertussis

Diphtheria: Toxoid of Corynebacterium diphtheriae

Tetanus: Toxoid of Clostridium tetani

Pertussis: Acellular Bordetella pertussis preparation


Immune response to diphtheria and tetanus toxoids is enhanced by acellular pertussis, which produces an inflammatory reaction at the site of injection


44
New cards

Vaccines Against Bacteria with Capsular Polysaccharides

  • Many pathogenic bacteria have an outer polysaccharide capsule

    • Subunit vaccines made of purified bacterial capsular polysaccharides can be effective in adults

    • children <18 months old and the elderly do not make good immune responses to capsular polysaccharides

      • children do not develop robust T-independent responses to polysaccharide antigens until a few years after birth

      • Solution: covalently link the polysaccharide to a carrier protein → Conjugate Vaccines


45
New cards

Haemophilus influenzae type B vaccine (HiB)

  • protects against meningitis in children

  • subunit vaccine

  • prepared from polysaccharide capsule of H. influenzae type B

    • to make this suitable for children under 18 months and the elderly, tetanus toxoid serves as a carrier protein, and provides antigenic peptides for stimulating a CD4+ T cell response

Conjugate vaccine

  • T cells responding to the protein carrier can stimulate HiB polysaccharide-specific B cells to make antibodies


46
New cards

Macromolecular complexes

  • recognized by both B and T cells make effective vaccines

  • naive B cell Ig binds carbohydrate epitope on a vaccine composed of polysaccharide conjugated to a tetanus toxoid, a protein. when the B cell degrades the vaccine conjugate, it can deliver the toxoid derived peptide to the TFH cell, which will help the T cell secrete cytokines that activate the B cell to differentiate into plasma cells


47
New cards

Streptococcus pneumoniae

Causes pneumonia

2 Capsular polysaccharides vaccines approved by FDA

  • Pneumococcal conjugate vaccine

    • recommended for infants and children

  • Pneumococcal polysaccharide vaccine


48
New cards

Meningococcal Vaccines

  • Meningitis is an infection that affects the delicate membranes (called meninges) that cover the brain and spinal cord

  • Disease is caused by a type of bacteria called Neisseria meningitidis

  • teenagers should get vaccinated for meningococcal disease

    • preteens should receive one dose of the serogroups of the bacteria A, C, W and Y

    • teens and young adults should receive a booster shot

      • they should also be vaccinated with serogroup B meningococcal vaccine


49
New cards

Meningitis Statistics

  • Approximately 1,000 people contract meningococcal disease in the U.S. each year

    • of those who get meningococcal disease, 15 percent die

  • Among those who survive, 20% live with permanent disabilities,

  • 1 in 5 U.S. teens have not yet received their first dose of the meningococcal vaccination against serogroups A, C, W and Y and remain unprotected


50
New cards

Bacille Calmette-Guérin (BCG) Vaccine

  • Live attenuated strain of Mycobacterium bovis (bovine strain of Mycobacterium

  • Vaccine against tuberculosis (TB) since 1921

  • No longer used in the US because it invalidates TB skin test

    • Simple test that verifies exposure to Mycobacterium tuberculosis, gives a false positive

  • BCG is given by intradermal injection to reduce the risk of neurovascular injury

    • very difficult to administer


51
New cards

Rotavirus and Results from Vaccination

  • India went from 99000 deaths in 2008 → 10000 deaths in 2016 after 13% of their residents got vaccinated

  • India went from 28000 deaths in 2008 → 3000 deaths in 2016 after 80% of their residents got vaccinated

  • Angola went from 9000 deaths in 2008 → 2000 deaths in 2016 after 58% of their residents got vaccinated


52
New cards

Two effective Rotavirus Vaccines

  1. Rotarix vaccine is an attenuated human rotavirus with VP7 G1 and VP4 P8 glycoproteins variants

  2. RotaTeq vaccine is based on a cattle rotavirus that is nonpathogenic to humans. consists of five viral strains

  • four of the strains express differenr human VP7 glycoprotein variants

  • one expresses cattle VP7 and human P8 variant of VP4


53
New cards

Adjuvants

Enhance the Immune response (non-specific)

modern adjuvants are TLR agonists

54
New cards

Vaccination with Neisseria factor H–binding protein (fHbp)

  • Neisseria uses fHbp to prevent complement fixation on its surface

    • fHbp is a surface lipoprotein that binds factor H and uses it to inactivate any C3b deposited on the bacterial surface

    • Factor I is used to cleave C3b into iC3b

    • prevents formation of the membrane attack complex and lysis of Neisseria

  • Vaccination generates high-affinity IgG antibodies against fHbp that cover up its binding site for factor H and:

    • prevents its interference with the complement activation by the alternative pathway

    • coating the bacteria with anti-fHbp IgG also activates classical pathway


55
New cards

Diarrheal disease

  • leading disease in global annual mortality

  • about 1.7 billion people are estimated to have been previously or currently infected



56
New cards

Post-Exposure to Hepatitis C virus

  • Less than 30% of people defeat the virus

  • More than 70% develop chronic infection


57
New cards

RNA Vaccines

  • based on mRNA inside a lipid membrane

    • fatty cover both protects mRNA when it first enters the body and helps it get to inside cells by fusing with cell membrane

  • effective but not long-lasting

  • when inside cell, machinery inside cell translates it into antigen protein

  • only lasts a few days but is sufficient to stimulate an immune response

  • naturally broken down and removed by the body. they are not capable of combining with the human genetic code (DNA)


58
New cards

Angiotensin-converting enzyme 2, or ACE2

  • Protein that provides the entry point for the coronavirus

  • break down angiotensin II into molecules that counteract angiotensin II’s harmful effects; but if the virus occupies the ACE2 ‘receptor’ on the surface of cells, then its role is blunted

  • Drugs called ACE inhibitors inhibit the formation of angiotensin II


59
New cards

Dengue (DEN4CYD) vaccine

Live attenuated tetravalent chimeric vaccine made using recombinant DNA technology by replacing the PrM (pre-membrane) and E (envelope) structural genes of yellow fever attenuated 17D strain vaccine with those from the four dengue serotypes.

Indicated for ages 9-16 years, with evidence of prior infection, who live in endemic areas (Puerto Rico, American Samoa, the U.S. Virgin Islands, the Federated States of Micronesia, the Republic of Marshall Islands, and the Republic of Palau).


60
New cards

Pathogen

an agent that can cause disease in healthy individuals

61
New cards

opportunistic pathogen

an agent that causes disease only when host defenses are weak

62
New cards

obligatory steps for pathogens

  • Attachment and entry into host cell

  • Multiplication

  • Local or systemic spread in the body

  • Evasion of host defense mechanisms

  • Transmission


63
New cards

Stages of Infection

  1. Infectious microorganism enters through epithelial tissues

  2. infectious agent must first adhere to the epithelial cells and then cross the epithelium

  3. local innate immune response may prevent an infection from being established

  • If not, innate response will::

    • help contain the infection

    • delivers infectious agent to local lymph nodes

      • initiate the adaptive response for eventual clearance of the infection


64
New cards

Survival Strategies of Pathogens

  • rapid replication

  • evasion of host response

  • inducing a minimal response

  • antigenic variation

  • suppression of host response


65
New cards

Macrophages

  • Found in healthy tissues

  • Variety of mature forms

  • Slightly increased levels during inflammation

  • Long-lived, survive after phagocytosis of pathogen


66
New cards

Neutrophils

  • Found only in inflamed tissues

  • Single mature form

  • Rapid increase in numbers during acute phase response

  • Short-lived, die after phagocytosis of pathogen


67
New cards

Genetic variation

within some species of pathogens that prevents humans from having long-term immunity

example: Streptococcus pneumoniae causes bacterial pneumonia, otitis media, meningitis

  • different strains, or serotypes of S. pneumoniae have antigenically different capsular polysaccharides

  • Antibodies against capsular polysaccharides bind to the pathogen to facilitate phagocytosis

  • A person infected with one serotype of S. pneumoniae clears the infection with type-specific antibody.

  • antibodies have no protective effect when the same person is infected with a different serotype of S. pneumoniae

    • therefore, the second infection can only be cleared by a new primary response


68
New cards

Genetic Variation using Streptococcus pneumoniae as an Example

  • Strains (serotypes) of S. pneumoniae have antigenically different capsular polysaccharides

  • antibodies against capsular polysaccharides opsonize the pathogen, causing phagocytosis

  • a person infected with S. pneumoniae can clear the infection with a type-specific antibody, but that same antibody won’t be able to protect that person from a subsequent infection with a different S. pneumoniae serotype


69
New cards

Influenza

  • RNA virus whose genome has 8 RNA segments

  • causes rapidly spreading, short-lived epidemics of respiratory tract infections

  • causes a worldwide pandemic every 10-50 yers

  • master of antigenic variation


70
New cards

Antigenic Drift

Antigenic variation due to accumulation of point mutations


example: in influenza, an individual infected with strain V produces antibodies against the viral hemagglutinin. in their secondary response, they will have antibodies that can bind to these hemagglutinin. However, point mutations within the hemagglutinin gene of strain V that originate in infections elsewhere eliminate the epitopes recognized by the protective antibodies. This allows the variant virus, strain V*, to successfully re-infect the individual immune to strain V.


71
New cards

Antigenic Shift

resulting from the reassortment of gene segments between two different strains that co-infect the same host cell


example: human influenza virus and an avian influenza virus simultaneously infect a cell within the secondary host, a pig, and their RNA segments become reassorted to produce a reassortant virus. this reassortant virus expresses hemagglutinin of avian origin which is different from the original human virus, which can now go infect humans who do not have an immune response to it yet.

72
New cards

Reassortment

form of genetic recombination that occurs in RNA viruses with segmented genomes

73
New cards

Trypanosomes

  • use gene rearrangements to change surface antigens


Trypanosoma brucei

  • african trypanosomiasis

  • causes sleeping sickness

  • insect bites transmits protozoa

    • multiply in the extracellular space b/w cell

    • surface proteins are encoded by >1000 genes

      • (Variable Surface Glycoproteins, VSG)

  • Causes progresive central nervous system (CNS) pathology involving meninges, choroid, blood brain barrier, immunopathological changes including perivascular infiltrations and alternations in the cytokine network


74
New cards

Variable Surface Glycoproteins (VSG)

Found on Trypanosomes

  • More than 1000 genes

  • many inactive trypanosome VSG genes but only one site for expression

  • once VSG-specific antibody is made, the other is expressed VSG gene is replaced by another VSG gene though gene oconversion

  • Successive rounds of gene conversion and expression of new VSG gene allow the parasite to flourish

  • causes a cycle in which parasite populations (red, yellow, and

    blue lines) alternate between high and low numbers


analogy: think of it like a vinyl and a record player, you can only play one vinyl at once, similarly you can only express one VSG gene at once

<p>Found on Trypanosomes</p><ul><li><p>More than 1000 genes</p></li><li><p>many inactive trypanosome VSG genes but only one site for expression</p></li><li><p>once VSG-specific antibody is made, the other is expressed VSG gene is replaced by another VSG gene though gene oconversion</p></li><li><p>Successive rounds of gene conversion and expression of new VSG gene allow the parasite to flourish</p></li><li><p>causes a cycle in which parasite populations (red, yellow, and</p><p>blue lines) alternate between high and low numbers</p></li></ul><p></p><p>analogy: think of it like a vinyl and a record player, you can only play one vinyl at once, similarly you can only express one VSG gene at once</p>
75
New cards

American Trypanosomiasis (Chagas Disease)

  • Trypanosoma cruzi does not have VSGs

  • hides from the immune system by living within host cells

  • taken up by phagocytosis and escapes from the lysozyme into the cytoplasm with the help of special protein that is activated at low pH

  • parasites divide intracellularly in infected muscle cells

  • Most people living with Chagas disease are unaware of their diagnosis, often until it’s too late :(

  • In California, has up to 100K people infected, it is a neglected tropical disease

  • spreads through an insect knwon as the “kissing bug”, with the most common being the Triatoma protracta


76
New cards

Herpesviruses

  • persist in human hosts by hiding from the immune response

  • Herpes simplex viruses cause:

    • cold sores (HSV-1)

    • genital herpes (HSV-2)

  • Varicella-zoster virus → chickenpox and shingles

  • epstein-barr virus → mononucleosis and cancer

  • Cytomegalovirus → birth defects and diseases in immunosuppressed patients


Herpesviruses cause:

  • acute infection

  • reactivated infections

    • recurrent herpes

    • shingles

  • certain cancers


77
New cards

How can the Immune Response be Blocked?

  • Human Cytomegalovirus (HCMV)

    • interferes with MHC Class I function in many ways

  • Multiple simultaneous strategies

  • 10 different proteins produced by CMV to block immune response, need to learn the following four:

    • US2: transports HLA class I to cytoplasm for degradation by proteasome

    • US3: retains HLA Class I in the endoplasmic reticulum by blocking tapasin function

    • UL83: Blocks access to the proteasome and the generation of MHC class I binding peptides

    • UL142: downregulates the expression of the MIC-A and MIC-B ligands of NKG2D

      • NKG2D is a receptor on NK cells and ɣδT cells that mediates the killing of MIC-expressing infected or cancer cells


78
New cards

Human Herpesviruses and Target Cells

Target cell for infection:

  • mucosal epithelial cells, B cells, monocytes, T cells and lympocytes are good target cells for infection


Target cell for latency:

  • neurons, B cells, monocytes, T cells


79
New cards

How does HSV (Herpes Simplex Virus) stay Persistent?

  • Immune response clears initial infection around the lips, leaves tissue damage to manifest as cold sores

  • in the meantime, the virus enters sensory neurons, i.e. those in the trigeminal ganglion whose axons innervate the lips, where it persists in latent state

    • various types of stress can cause virus to leave neurons and reinfect epithelium, then reactivates the immune response and causes cold sores.

  • people with HSV periodically get cold sores due to this process

  • transmission of the virus from one person to another is easier during this state


80
New cards

Bacterial Superantigens

  • bind α:β T cell receptors and MHC class II in a non-specific manner

  • causes massive but inappropriate “cytokine storm”

    • T cells are over-stimulated and produce high levels of proinflammatory cytokines such as IL-1, IL-2, IL-6 and TNF-alpha

  • can lead to septic shock, aka when immune system overreacts


81
New cards

Evasion of IgA-mediated defense by bacterial superantigen

  • combination of specific IgA and FcaR1 on phagocytes eliminates bacteria that breach a mucosal barrier and infect the underlying tissue

  • Staphylococcal Superantigen-Like Protein 7 (SSLP7) blocks this mechanism for disposing of bacteria

  • by binding both C5 and the Fc region of IgA, SSLP7:

    • prevents IgA from binding to the FcaR1 receptor on phagocytes, avoiding phagocytosis

    • Blocks the activation of complement-mediated killing of the bacteria by the membrane attack complex



<ul><li><p>combination of specific IgA and FcaR1 on phagocytes eliminates bacteria that breach a mucosal barrier and infect the underlying tissue </p></li><li><p>Staphylococcal Superantigen-Like Protein 7 (SSLP7) blocks this mechanism for disposing of bacteria</p></li><li><p>by binding both C5 and the Fc region of IgA, SSLP7:</p><ul><li><p>prevents IgA from binding to the FcaR1 receptor on phagocytes, avoiding phagocytosis</p></li><li><p>Blocks the activation of complement-mediated killing of the bacteria by the membrane attack complex</p></li></ul></li><li><p></p></li></ul><p></p>
82
New cards

Eight Functional Groups of Primary Immunodeficiency Syndrome

  1. Immunodeficiencies affecting cellular and humoral immunity

  2. Combined immunodeficiencies with associated or syndromic features

  3. Predominantly antibody deficiencies

  4. Diseases of immune dysregulation

  5. Congenital defects of phagocyte number, function, or both

  6. Defects in intrinsic and innate immunity

  7. Autoinflammatory disorders

  8. Complement deficiencies


All of these groups are major autosomal recessive alleles, with the exception of group 7 which are mainly Autosomal dominant alleles


83
New cards

X-Linked Agammaglobulinemia (XLA)

  • In XLA, B cells do not develop beyond the pre-B-cell stage, Bruton’s tyrosine kinase (BTK) is defective. Pre-B-cell receptor cannot generate intracellular signals, no light chain added

  • this leads to recurrent bacterial infections

  • males are more affected because they only have one X chromosome and there is no BTK gene on the smaller Y chromosome

  • heterozygous females are carriers of the trait but are themselves healthy

    • cells in all females randomly inactivate one X chromosome, leading to B cell development arrest if the female is a carrier for XLA and inactivates the normal X


84
New cards

Deficiencies in Pathways of Complement Activation

Immune complex diseases are inflammatory conditions characterized by antigen-antibody deposition and activation of complement

Remember these:

• Deficiency in C1, C2, and C4 causes immune complex diseases

• Deficiency in C3 causes susceptibility to encapsulated bacteria

• Deficiency in C5-C9 causes susceptibility to Neisseria

• Deficiency in DAF and CD59 causes autoimmune-like conditions including

paroxysmal nocturnal hemoglobinuria

• Deficiency in C1INH causes Hereditary Angioedema (HAE)

85
New cards

C1INH

  • inactivates C1r and C1s enzymes

  • is a protease inhibitor

  • acts as a pseudosubstrate

  • permanent covalent linkage to the protease

  • deficiency in C1INH causes hereditary angioedema


When you have an infection, you want to use complement and then you want to turn it off to not cause more damage. Hereditary angioedema is inflammation of the blood vessels with edema


86
New cards

Examples of Defects in Phagocytic Cells → Persistent Bacterial Infections

  • Chronic granulomatous disease, necessary for oxidative burst to kill bacteria that are engulfed. No respiratory burst means can’t kill pathogen

  • Chediak-higashi syndrome: defective phagocytosis, also with endosomes, can’t get lysosomes inside to kill pathogens


87
New cards

Granuloma

aggregation of macrophages that forms in response to chronic inflammation. This occurs when the immune system attempts to isolate foreign substances that it is otherwise unable to eliminate


Body is not able to eliminate the pathogen, this is a compromise. Going to trap bacteria in there and it might be able to replicate but it is not leaving the structure

88
New cards

Severe Combined Immune Deficiencies (SCID)

Several types:

  • X-Linked: mutation in gene coding for common gamma chain (ɣ) needed for several cytokine receptors (IL-2R, IL-4R)

  • Wiskott-Aldrich Syndrome: X-linked deficiency of T cell activation. Defect in the gene for a protein needed for cytoskeletal reorganization, poor antibody responses

  • Omenn Syndrome: RAG Defects, deficient VDJ gene segment recombination

    • no functional T or B cells

  • Adenosine Deaminase Deficiency: Defect in purine degradation. Nucleotide metabolites accumulate and are toxic to developing T and B cells

    • some children treated by gene therapy


89
New cards

Impairment of Intracellular bacterial infection responses

IL-12 receptor and IFN-γ receptor deficiency

these deficiencies affect both innate and adaptive immunity because you use IL-12, IL-12 activates neutrophils in innate immunity, in adaptive immunity, it activates effector T cells and macrophages in the adaptive immune response

90
New cards

Origins of HIV and AIDS

Chimpanzee; HIV-1

Sooty mangabey; HIV-2

91
New cards

Acquired Immunodeficiency Syndrome (AIDS)

  • Caused by: Human Immunodeficiency Virus (HIV)

    • Profound immunosuppression

    • opportunistic infections

    • malignancies

    • wasting

    • CNS degreation

  • HIV Receptor is CD4, meaning it targets CD4+ cells

  • Main Co-receptors for HIV are Chemokine Receptors:

    • CCR5

    • CXCR4


92
New cards

HIV Viral Structure

Lipid bilayer, 3 major enzymes, integrase, protease, reverse transcriptase


Has glycoproteins such as gp120 and gp41 that bind to T cell receptors, they also form the viral spike

93
New cards

HIV Receptor and Co-receptor

Interaction b/w GP120 and envelope glycoprotein with both the receptor CD4 and a chemokin co-receptor. HIV uses reverse transcriptase to make ssDNA from mRNA, which is then made into a dsDNA that can integrate into our genes

94
New cards

HIV-2 is not as deadly as HIV-1

  • disease caused by HIV-2 depends on the viral load

  • With a viral load of 100 or less the infection is controlled, and those infected survive for as long as the uninfected control population does

    • people with HIV-2 generally live longer/as long as normal people


95
New cards

HIV Infection Cycle

  1. GP120 envelope protein of virus binds to CD4, which also enables it to bind the co-receptor

  2. Binding releases GP41, causing fusion of viral envelope with plasma membrane and release of viral core into the cytoplasm

  3. RNA genome is release and reverse transcribed into double stranded complementary DNA (cDNA)

  4. DNA migrates to nucleus in association with viral integrate and becomes integrated into cell genome as a provirus

  5. activation of T cell causes low level transcription of provirus into mRNA that directs synthesis of early proteins Tat and Rev

  6. proteins change the pattern of provirus transcriptions to produce mRNA encoding protein constituents of the virion and RNA molecules corresponding to the HIV genome

  7. envelope proteins travel to plasma membrane, and other viral proteins and viral genomic RNA assemble into nucleocapsids

  8. new virus particles bud from the cell, acquiring their lipid envelope and envelope glycoproteins in the process


96
New cards

Effects on CD4 T cells due to HIV

  • gradual reduction of CD4 T Cells

  • opportunistic infections and other symptoms become more frequent as CD4 T Cell count starts falling (around 500 cells/µL). Humans normally have 1000 cells/µL, and around 200 cells/µL is when the patient is diagnosed as having AIDs


97
New cards

Effects of AIDs due to age

  • rate of progression to AIDS of HIV-infected people increases with age because capacity to generate new T cells decreases with age


Example: In order to treat hemophilia, blood from healthy donors was infused into the hemophiliac. However, in the early 1980s, some healthy blood donors contracted HIV, therefore leading to infections in recipients of the blood. Research showed that rate progression to AIDs of HIV infected people increases with age.


Now we have Recombinant Coagulation factors, a new way to treat hemophiliacs without the risk of contracting HIV


98
New cards

Natural Course of HIV Infection

  • early phase → adaptive immune response being activated so the virus reaches high levels

  • mid phase → production of HIV-specific antibodies and cytotoxic T cells, virus is controlled but not eliminated

  • later phase → destruction of CD4 T cells outstrips their renewal, adaptive immunity declines and levels of virus increase again


99
New cards

HIV and Protease Inhibitor Drugs

  • when patient is treated w/ one type of protease inhibitor drug, decrease in viral load and increase in CD4T-cells numbers are not permanent

    • drug selects for rare drug-resistant HIV variants that rapidly increase in number and continue the progression to AIDs


100
New cards

Anti-retroviral combination therapy

  • can reduce HIV to undetectable levels in the blood

  • virus remains in the lymphoid tissue

  • can increase the number of circulating CD4 T cells

  • infected cells only live for a few days once infected, and administering the anti-retroviral drug blocks the viral life cycle. Existing virions in the blood are rapidly cleared by the actions of neutralizing antibody, complement and phagocytes

    • therefore, newly produced CD4 T cells are uninfected, living longer and accumulating in circulation

    • essentially, this drug attempts to block some part of viral replication